These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6471583)

  • 41. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J; Brunfaut C
    J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
    [No Abstract]   [Full Text] [Related]  

  • 42. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA; Fallon MD; Harter HR; Hruska KA; Slatopolsky E; Teitelbaum SL
    J Clin Endocrinol Metab; 1986 Apr; 62(4):747-52. PubMed ID: 3949954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy.
    Silverberg DS; Bettcher KB; Dossetor JB; Overton TR; Holick MF; DeLuca HF
    Can Med Assoc J; 1975 Jan; 112(2):190, 193-5. PubMed ID: 1111876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum phosphorus control in dialysis patients with aluminum hydroxide gel-containing cookies.
    Ogden DA; Hurley E; Witt E; Heitsman C; Cazee C
    Proc Clin Dial Transplant Forum; 1972; 2():166-70. PubMed ID: 4681306
    [No Abstract]   [Full Text] [Related]  

  • 46. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 47. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis.
    Cassidy MJ; Owen JP; Ellis HA; Dewar J; Robinson CJ; Wilkinson R; Ward MK; Kerr DN
    Q J Med; 1985 Jan; 54(213):29-48. PubMed ID: 3975345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U
    Minerva Med; 1985 Mar; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract]   [Full Text] [Related]  

  • 52. Bone disease in patients dialyzed with untreated water.
    Rashid A; Posen GA; Gray D; Jaworski ZF
    Med Instrum; 1974; 8(3):204-6. PubMed ID: 4838450
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoride metabolism in uremia.
    Nielsen E; Solomon N; Goodwin NJ; Siddhivarn N; Galonsky R; Taves D; Friedman EA
    Trans Am Soc Artif Intern Organs; 1973; 19():450-5. PubMed ID: 4722761
    [No Abstract]   [Full Text] [Related]  

  • 55. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 56. [Potentials for the early diagnosis of renal osteodystrophy in patients with chronic kidney failure during treatment by systematic hemodialysis].
    Shcherbakova EO; Fekson EG; Cherniakov VL; Shcherbakov VA
    Urol Nefrol (Mosk); 1985; (2):58-60. PubMed ID: 3992758
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiography of healing dialysis osteodystrophy.
    Barmeir E; Dubowitz B; Hudson GA; Milne FJ; Meyers AM
    Acta Radiol Diagn (Stockh); 1984; 25(2):107-12. PubMed ID: 6375266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Course and significance of various biochemical parameters in 1,25-dihydroxyvitamin D3 therapy of uremic osteodystrophy].
    Giachino G; Giacchino F; Basolo B; Giraudo G; Boero R; Bancale E; Nigra M; Garetto A; Jeantet A; Piccoli G
    Arch Sci Med (Torino); 1983; 140(3):259-66. PubMed ID: 6689545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlations between laboratory and roentgenologic data of renal osteodystrophy in patients treated in a chronic hemodialysis program].
    Löcsey L; Gyarmati J; Kakuk G; Gyarmati J; Barnák G; Leövey A
    Orv Hetil; 1979 Oct; 120(41):2475-82. PubMed ID: 545226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.